Skip to content

Testing a Device for Automatically TRacking Urine and STool in an Inpatient HCT Setting (Project TRUST)

Testing a Device for Automatically TRacking Urine and STool in an Inpatient HCT Setting (Project TRUST)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05520346
Enrollment
54
Registered
2022-08-29
Start date
2023-09-13
Completion date
2028-08-01
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fluid Output

Keywords

toilet device

Brief summary

The purpose of this study is to determine whether a prototype toilet device that we have developed can accurately and automatically track human fluid output from renal and gastrointestinal systems in the hospital. The device includes components that can be outfitted onto existing toilets. In this study, participants' hospital rooms will be outfitted with the prototype toilet device. Participants will use the toilet as usual throughout the duration of their inpatient stay. Sometimes output will be measured by the device, and other times output will be measured manually by nurses.

Interventions

DEVICEElectronic Device for Toilet

Device will be installed on toilet of patients will in hospital to measure all waste output.

Sponsors

Duke University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Scheduled to undergo an allogeneic or autologous hematopoietic stem cell transplant for any cancer or non-cancer illness through the Duke ABMT clinic OR currently undergoing treatment for HF in the Duke Cardiology Clinic with order of strict I/O monitoring 2. Age 18-80 years 3. Karnofsky Performance Scale (KPS) ≥ 70 if a BMT patient 4. Able to read/write English

Exclusion criteria

1. Inability to use toilet device due to physical constraints, e.g. waste excreted through stoma or catheter. 2. Physician recommendation that patient does not use standard urine/stool collection hat during days 1-2 of HCT conditioning OR during HF treatment. 3. Women who are pregnant 4. Patient height \< 5'3" if they are a patient within the Duke Cardiology Clinic 5. Disabled individuals using wheelchairs or transfer devices to use bathroom

Design outcomes

Primary

MeasureTime frame
Mean absolute error of urine volume (in mL) as measured by device compared to standard of care nurse assessmentUp to 14 days

Secondary

MeasureTime frame
Correlation between daily patient fluid balance (difference between fluid input and output in mL) as measured by device measurements or standard of care nurse assessment and the change in daily weightUp to 14 days
Mean absolute error of urine volume (in mL) as measured by deviceUp to 14 days
Time (in mins) spent handling/recording patient wasteFirst 3 days of patient's HCT conditioning
Time (in mins) between nurse logging of patient urination in electronic medical records and device-based logging of patient urinationUp to 14 days
Percent of patients who indicated device satisfaction as measured by patient surveyDay 3 of HCT conditioning
Percent of nurses who indicated device satisfaction as measured by nurse surveyAfter transition to Stage 2 - about 3 days after patient begins HCT conditioning
Number of patient falls as measured by patient reportUp to 17 days

Countries

United States

Contacts

CONTACTLauren Hill
lauren.hill@duke.edu919-668-2369
CONTACTAmy Bush
amy.bush@duke.edu+1 919 668 1085
PRINCIPAL_INVESTIGATORChenyu Lin, MD

Duke University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 11, 2026